Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats

Journal of Food and Drug Analysis

Volumn 13, Issue 3, 2005, Pages 244-250

  Yang, Chi Yu ^a   Hsiu, Su Lan ^a   Wen, Kuo Ching ^a   Lin, Shiuan Pey ^a   Tsai, Shang Yuan ^a   Hou, Yu Chi ^a   Chao, Pei Dawn Lee ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Conjugated metabolites; Glucuronides; Pharmacokinetics; Quercetin; Rutin; Sulfates

Indexed keywords

BETA GLUCURONIDASE; DRUG METABOLITE; QUERCETIN; RUTOSIDE; SULFATASE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MATHEMATICAL MODEL; MEAN RESIDENCE TIME; NONHUMAN; RAT;

ANIMALIA;

EID: 28044467747     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Harborne, J. B. and Williams, C. A. 2000. Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
2. Wang, H. K. 2000. The therapeutic potential of flavonoids. Expert. Opin. Invest. Drug. 9: 2019-2103.
3. Knekt, P., Jarvinen, R., Reunanen, A. and Maatela, J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312: 478-481.
4. Hertog, M. G. L., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menott, A., Nedelijkovic, S., Pekkarinen, M., Simic, B. S., Toshoma, H., Feskens, E. J. M., Hollman, P. C. H. and Katan, M. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155: 381-386.
5. Cook, N. C. and Samman, S. 1996. Flavonoids - chemistry, metabolism, cardioprotective effects and dietary sources. J. Nutr. Biochem. 7: 66-76.
6. Horvathova, K., Novotny, L. and Vachalkova, A. 2003. The free radical scavenging activity of four flavonoids determined by the comet assay. Neoplasma 50: 291-295.
7. Park, Y. C., Rimbach, G., Saliou, C., Valacchi, G. and Packer, L. 2000. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-α secretion, and NF-κB-dependent gene expression in RAW 264.7 macrophages. FEBS. Lett. 464: 93-97.
8. van der Logt, E. M., Roelofs, H. M., Nagengast, F. M. and Peters, W. H. 2003. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24: 1651-1656.
9. Birt, D. F., Hendrich, S. and Wang, W. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90: 157-177.
10. Wang, Y. H., Chao, P. D. L., Hsiu, S. L., Wen, K. C. and Hou, Y. C. 2004. Lethal quercetin-digoxin interaction in pigs. Life Sci. 74: 1191-1197.
11. Hsiu, S. L., Hou, Y. C., Wang, Y. H., Tsao, C. W., Su, S. F. and Chao, P. D. L. 2002. Quercetin significantly decreased cyclosporine oral bioavailability in pigs and rats. Life Sci. 72: 227-235.
12. Shanno, R. L. 1946. Rutin: a new drug for the treatment of increased capillary fragility. Am. J. Med. Sci. 211: 539-543.
13. Park, S. Y., Bok, S. H., Jeon, S. M., Park, Y. B., Lee, S. J., Jeong, T. S. and Choi, M. S. 2002. Effect of rutin and tannic acid supplements on cholesterol metabolism in rats. Nutr. Res. 22: 283-295.
14. Shen, J. R., Hsiao, G., Chou, P. H., Shen, M. Y. and Chou, D. S. 2004. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J. Agric. Food Chem. 52: 4414-4418.
15. Hollman, P. C. H. and Katan, M. B. 1997. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 51: 305-310.
16. Manach, C., Morand, C. and Texier, O. 1995. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 125: 1911-1922.
17. Watson, D. G. and Oliveira, E. J. 1999. Solid-phase extraction and gas chromatography-mass spectrometry determination of kaempferol and quercetin in human urine after consumption of Ginkgo biloba tablets. J. Chromatogr. B. Biomed. Sci. Appl. 723: 203-210.
18. Morand, C., Crespy, V., Manach, C., Besson, C., Demigne, C. and Remesy, C. 1998. Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275: 212-219.
19. Graefe, E. U., Wittig, J., Mueller, S., Riethling, A. K., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H. and Veit, M. 2001. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41: 492-499.
20. Khaled, K. A., El-Sayed, Y. M. and Al-Hadiya, B. M. 2003. Disposition in of the flavonoid quercetin in rats after single intervenous and oral doses. Drug Dev. Ind. Pharm. 30: 397-403.
21. Crespy, V., Morand, C., Manach, C., Besson, C., Demigne, C. and Remesy, C. 1999. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am. J. Physiol. Gastrointest. Liver Physiol. 277: 120-126.
22. Liu, Y., Liu, Y., Dai, Y., Xun, L. and Hu, M. 2003. Enteric disposition and recycling of flavonoids and ginkgo flavonoids. J. Altern. Complement Med. 9: 631-640.
23. Lai, M. Y., Hsiu, S. L., Hou, Y. C., Tsai, S. Y. and Chao, P. D. L. 2003. Comparison of Metabolic pharmacokinetics of baicalin and baicalein in rats. J. Pharm. Pharmacol. 55: 199-209.
24. Hsiu, S. L., Huang, T. Y., Hou, Y. C. and Chao, P. D. L. 2002. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci. 70: 1481-1489.
25. Spencer, J. P., Chowrimootoo, G., Choudhury, R., Debnam, E. S., Srai, S. K. and Rice-Evans, C. 1999. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS. Letters 458: 224-230.
26. Day, A. J., Mellon, F., Barron, D., Sarrazin, G., Morgan, M. R. and Williamson, G. 2001. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res. 35: 941-952.
27. 14C] quercetin-4′-glucoside. J. Agric. Food Chem. 50: 6902-6909.
28. Shirai, M., Yamanishi, R., Moon, J. H., Murota, K. and Terao, J. 2002. Effect of quereetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Biosci. Biotechnol. Biochem. 66: 1015-1021.
29. Fang, S. H., Hou, Y. C., Chang, W. C., Hsiu, S. L., Chao, P. D. L. and Chiang, B. L. 2003. Morin sulfates/glucuronindes exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci. 74: 743-756.